Avitar, Inc.
Avitar, Inc. AVTI Peers
See (AVTI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVTI | $0.00 | N/A | 1382.00 | N/A | N/A | N/A |
| SMMNY | $26.81 | -2.12% | 120.29B | 25.78 | $1.04 | +1.20% |
| SEMHF | $55.28 | +3.52% | 62.00B | 26.58 | $2.08 | +2.01% |
| RYLPF | $24.21 | +2.30% | 22.40B | 83.49 | $0.29 | +3.89% |
| SONVY | $67.98 | +0.73% | 20.33B | 31.62 | $2.15 | +1.40% |
| SONVF | $340.94 | +5.13% | 20.32B | 31.69 | $10.76 | +1.69% |
| SNNUF | $14.84 | +1.68% | 12.99B | 31.57 | $0.47 | +2.53% |
| CHEOY | $89.71 | +4.00% | 11.73B | 49.02 | $1.83 | +1.56% |
| CHEOF | $170.00 | +1.19% | 11.09B | 46.45 | $3.66 | +1.63% |
| WILYY | $19.25 | +3.38% | 8.43B | 19.44 | $0.99 | N/A |
Stock Comparison
AVTI vs SMMNY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SMMNY has a market cap of 120.29B. Regarding current trading prices, AVTI is priced at $0.00, while SMMNY trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SMMNY's P/E ratio is 25.78. In terms of profitability, AVTI's ROE is +0.25%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, AVTI is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs SEMHF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SEMHF has a market cap of 62.00B. Regarding current trading prices, AVTI is priced at $0.00, while SEMHF trades at $55.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SEMHF's P/E ratio is 26.58. In terms of profitability, AVTI's ROE is +0.25%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, AVTI is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs RYLPF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, RYLPF has a market cap of 22.40B. Regarding current trading prices, AVTI is priced at $0.00, while RYLPF trades at $24.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas RYLPF's P/E ratio is 83.49. In terms of profitability, AVTI's ROE is +0.25%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, AVTI is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs SONVY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SONVY has a market cap of 20.33B. Regarding current trading prices, AVTI is priced at $0.00, while SONVY trades at $67.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SONVY's P/E ratio is 31.62. In terms of profitability, AVTI's ROE is +0.25%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, AVTI is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs SONVF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SONVF has a market cap of 20.32B. Regarding current trading prices, AVTI is priced at $0.00, while SONVF trades at $340.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SONVF's P/E ratio is 31.69. In terms of profitability, AVTI's ROE is +0.25%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, AVTI is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs SNNUF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SNNUF has a market cap of 12.99B. Regarding current trading prices, AVTI is priced at $0.00, while SNNUF trades at $14.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SNNUF's P/E ratio is 31.57. In terms of profitability, AVTI's ROE is +0.25%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, AVTI is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs CHEOY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CHEOY has a market cap of 11.73B. Regarding current trading prices, AVTI is priced at $0.00, while CHEOY trades at $89.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CHEOY's P/E ratio is 49.02. In terms of profitability, AVTI's ROE is +0.25%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, AVTI is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs CHEOF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CHEOF has a market cap of 11.09B. Regarding current trading prices, AVTI is priced at $0.00, while CHEOF trades at $170.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CHEOF's P/E ratio is 46.45. In terms of profitability, AVTI's ROE is +0.25%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, AVTI is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs WILYY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, WILYY has a market cap of 8.43B. Regarding current trading prices, AVTI is priced at $0.00, while WILYY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas WILYY's P/E ratio is 19.44. In terms of profitability, AVTI's ROE is +0.25%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, AVTI is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs WILLF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, WILLF has a market cap of 7.86B. Regarding current trading prices, AVTI is priced at $0.00, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas WILLF's P/E ratio is 19.31. In terms of profitability, AVTI's ROE is +0.25%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, AVTI is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs GNGBY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, GNGBY has a market cap of 5.48B. Regarding current trading prices, AVTI is priced at $0.00, while GNGBY trades at $19.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas GNGBY's P/E ratio is 36.12. In terms of profitability, AVTI's ROE is +0.25%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, AVTI is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs GNGBF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, AVTI is priced at $0.00, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, AVTI's ROE is +0.25%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, AVTI is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs AMBBY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, AMBBY has a market cap of 4.18B. Regarding current trading prices, AVTI is priced at $0.00, while AMBBY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas AMBBY's P/E ratio is 75.05. In terms of profitability, AVTI's ROE is +0.25%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, AVTI is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs NHNKY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, NHNKY has a market cap of 4.04B. Regarding current trading prices, AVTI is priced at $0.00, while NHNKY trades at $12.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas NHNKY's P/E ratio is 21.01. In terms of profitability, AVTI's ROE is +0.25%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, AVTI is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs AMBFF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, AMBFF has a market cap of 4.02B. Regarding current trading prices, AVTI is priced at $0.00, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, AVTI's ROE is +0.25%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, AVTI is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs NHNKF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, AVTI is priced at $0.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, AVTI's ROE is +0.25%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, AVTI is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs VTRLY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, AVTI is priced at $0.00, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, AVTI's ROE is +0.25%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, AVTI is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs STSEY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, AVTI is priced at $0.00, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas STSEY's P/E ratio is 39.41. In terms of profitability, AVTI's ROE is +0.25%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, AVTI is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs GNNDY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, GNNDY has a market cap of 2.02B. Regarding current trading prices, AVTI is priced at $0.00, while GNNDY trades at $41.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas GNNDY's P/E ratio is 16.74. In terms of profitability, AVTI's ROE is +0.25%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, AVTI is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs SSII Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SSII has a market cap of 1.89B. Regarding current trading prices, AVTI is priced at $0.00, while SSII trades at $9.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SSII's P/E ratio is -121.75. In terms of profitability, AVTI's ROE is +0.25%, compared to SSII's ROE of -1.33%. Regarding short-term risk, AVTI is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs GGNDF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, GGNDF has a market cap of 1.81B. Regarding current trading prices, AVTI is priced at $0.00, while GGNDF trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas GGNDF's P/E ratio is 14.95. In terms of profitability, AVTI's ROE is +0.25%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, AVTI is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs OSSFF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, AVTI is priced at $0.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, AVTI's ROE is +0.25%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, AVTI is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs DWRKF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, AVTI is priced at $0.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, AVTI's ROE is +0.25%, compared to DWRKF's ROE of N/A. Regarding short-term risk, AVTI is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs MCRPF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, AVTI is priced at $0.00, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, AVTI's ROE is +0.25%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, AVTI is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs OSSUY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, AVTI is priced at $0.00, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, AVTI's ROE is +0.25%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, AVTI is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs MEDGF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, AVTI is priced at $0.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, AVTI's ROE is +0.25%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, AVTI is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs DRWKF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, DRWKF has a market cap of 1.18B. Regarding current trading prices, AVTI is priced at $0.00, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas DRWKF's P/E ratio is 9.10. In terms of profitability, AVTI's ROE is +0.25%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, AVTI is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs DGWPF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, DGWPF has a market cap of 1.18B. Regarding current trading prices, AVTI is priced at $0.00, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas DGWPF's P/E ratio is 8.70. In terms of profitability, AVTI's ROE is +0.25%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, AVTI is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs XVIPF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, AVTI is priced at $0.00, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, AVTI's ROE is +0.25%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, AVTI is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs LFTSF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, AVTI is priced at $0.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, AVTI's ROE is +0.25%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, AVTI is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs CALZF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CALZF has a market cap of 829.01M. Regarding current trading prices, AVTI is priced at $0.00, while CALZF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CALZF's P/E ratio is 120.00. In terms of profitability, AVTI's ROE is +0.25%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, AVTI is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs MDRSF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, AVTI is priced at $0.00, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, AVTI's ROE is +0.25%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, AVTI is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs ELEAF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, ELEAF has a market cap of 759.57M. Regarding current trading prices, AVTI is priced at $0.00, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas ELEAF's P/E ratio is 11.15. In terms of profitability, AVTI's ROE is +0.25%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, AVTI is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs AVMR Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, AVTI is priced at $0.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas AVMR's P/E ratio is -18.34. In terms of profitability, AVTI's ROE is +0.25%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, AVTI is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs CLVSF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, AVTI is priced at $0.00, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, AVTI's ROE is +0.25%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, AVTI is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs IOBCF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, IOBCF has a market cap of 388.16M. Regarding current trading prices, AVTI is priced at $0.00, while IOBCF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas IOBCF's P/E ratio is 38.97. In terms of profitability, AVTI's ROE is +0.25%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, AVTI is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs HYBT Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, AVTI is priced at $0.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas HYBT's P/E ratio is N/A. In terms of profitability, AVTI's ROE is +0.25%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, AVTI is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs EAPIF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, AVTI is priced at $0.00, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas EAPIF's P/E ratio is -1.98. In terms of profitability, AVTI's ROE is +0.25%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, AVTI is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs CSSPF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, AVTI is priced at $0.00, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, AVTI's ROE is +0.25%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, AVTI is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs CLLKF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CLLKF has a market cap of 259.03M. Regarding current trading prices, AVTI is priced at $0.00, while CLLKF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CLLKF's P/E ratio is -8.52. In terms of profitability, AVTI's ROE is +0.25%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, AVTI is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs SNWV Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SNWV has a market cap of 253.08M. Regarding current trading prices, AVTI is priced at $0.00, while SNWV trades at $29.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SNWV's P/E ratio is -4.75. In terms of profitability, AVTI's ROE is +0.25%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, AVTI is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs CYBQY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CYBQY has a market cap of 250.50M. Regarding current trading prices, AVTI is priced at $0.00, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, AVTI's ROE is +0.25%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, AVTI is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs HTLZF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, AVTI is priced at $0.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, AVTI's ROE is +0.25%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, AVTI is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs BCCOY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, BCCOY has a market cap of 221.04M. Regarding current trading prices, AVTI is priced at $0.00, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, AVTI's ROE is +0.25%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, AVTI is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs IMPZY Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, AVTI is priced at $0.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, AVTI's ROE is +0.25%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, AVTI is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs AVHHL Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, AVHHL has a market cap of 176.38M. Regarding current trading prices, AVTI is priced at $0.00, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, AVTI's ROE is +0.25%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, AVTI is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs CYBQF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, AVTI is priced at $0.00, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, AVTI's ROE is +0.25%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, AVTI is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs BRNHF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, AVTI is priced at $0.00, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, AVTI's ROE is +0.25%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, AVTI is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs EKDHF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, AVTI is priced at $0.00, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, AVTI's ROE is +0.25%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, AVTI is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs JMDMF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, AVTI is priced at $0.00, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, AVTI's ROE is +0.25%, compared to JMDMF's ROE of N/A. Regarding short-term risk, AVTI is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs PXMBF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, PXMBF has a market cap of 150.49M. Regarding current trading prices, AVTI is priced at $0.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, AVTI's ROE is +0.25%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, AVTI is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs BRSYF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, AVTI is priced at $0.00, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, AVTI's ROE is +0.25%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, AVTI is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs AMEUF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, AVTI is priced at $0.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, AVTI's ROE is +0.25%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, AVTI is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs VMTHF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, AVTI is priced at $0.00, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, AVTI's ROE is +0.25%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, AVTI is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs FDMDF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, AVTI is priced at $0.00, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, AVTI's ROE is +0.25%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, AVTI is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs RSHUF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, AVTI is priced at $0.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, AVTI's ROE is +0.25%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, AVTI is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for AVTI.
AVTI vs CKMTF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, AVTI is priced at $0.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, AVTI's ROE is +0.25%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, AVTI is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs SOMNF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, AVTI is priced at $0.00, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, AVTI's ROE is +0.25%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, AVTI is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs DMTRF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, AVTI is priced at $0.00, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, AVTI's ROE is +0.25%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, AVTI is more volatile compared to DMTRF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs IPDQF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, AVTI is priced at $0.00, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, AVTI's ROE is +0.25%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, AVTI is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs SNZZF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, AVTI is priced at $0.00, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, AVTI's ROE is +0.25%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, AVTI is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs RDGL Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, RDGL has a market cap of 59.64M. Regarding current trading prices, AVTI is priced at $0.00, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas RDGL's P/E ratio is -13.15. In terms of profitability, AVTI's ROE is +0.25%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, AVTI is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs BLOZF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, BLOZF has a market cap of 49.51M. Regarding current trading prices, AVTI is priced at $0.00, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas BLOZF's P/E ratio is -21.50. In terms of profitability, AVTI's ROE is +0.25%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, AVTI is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs NVYTF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, AVTI is priced at $0.00, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, AVTI's ROE is +0.25%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, AVTI is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs TLTFF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, TLTFF has a market cap of 32.19M. Regarding current trading prices, AVTI is priced at $0.00, while TLTFF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas TLTFF's P/E ratio is -12.99. In terms of profitability, AVTI's ROE is +0.25%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, AVTI is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs PYNKF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, PYNKF has a market cap of 29.84M. Regarding current trading prices, AVTI is priced at $0.00, while PYNKF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas PYNKF's P/E ratio is -1.77. In terms of profitability, AVTI's ROE is +0.25%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, AVTI is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs ELXMF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, AVTI is priced at $0.00, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, AVTI's ROE is +0.25%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, AVTI is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs KBBTF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, AVTI is priced at $0.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, AVTI's ROE is +0.25%, compared to KBBTF's ROE of N/A. Regarding short-term risk, AVTI is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs EMITF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, AVTI is priced at $0.00, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas EMITF's P/E ratio is -14.29. In terms of profitability, AVTI's ROE is +0.25%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, AVTI is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs POSC Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, POSC has a market cap of 20.56M. Regarding current trading prices, AVTI is priced at $0.00, while POSC trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas POSC's P/E ratio is 0.42. In terms of profitability, AVTI's ROE is +0.25%, compared to POSC's ROE of +9.25%. Regarding short-term risk, AVTI is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs ASAPF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, ASAPF has a market cap of 18.06M. Regarding current trading prices, AVTI is priced at $0.00, while ASAPF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas ASAPF's P/E ratio is -23.39. In terms of profitability, AVTI's ROE is +0.25%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, AVTI is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs VPTDF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, VPTDF has a market cap of 17.63M. Regarding current trading prices, AVTI is priced at $0.00, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas VPTDF's P/E ratio is -5.40. In terms of profitability, AVTI's ROE is +0.25%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, AVTI is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs MDXHF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, MDXHF has a market cap of 16.37M. Regarding current trading prices, AVTI is priced at $0.00, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, AVTI's ROE is +0.25%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, AVTI is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs TMDIF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, AVTI is priced at $0.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, AVTI's ROE is +0.25%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, AVTI is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for AVTI.
AVTI vs DIZTF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, AVTI is priced at $0.00, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, AVTI's ROE is +0.25%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, AVTI is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs PLLWF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, AVTI is priced at $0.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, AVTI's ROE is +0.25%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, AVTI is more volatile compared to PLLWF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs RMSL Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, RMSL has a market cap of 13.20M. Regarding current trading prices, AVTI is priced at $0.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas RMSL's P/E ratio is 0.86. In terms of profitability, AVTI's ROE is +0.25%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, AVTI is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs IMEXF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, IMEXF has a market cap of 11.63M. Regarding current trading prices, AVTI is priced at $0.00, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas IMEXF's P/E ratio is N/A. In terms of profitability, AVTI's ROE is +0.25%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, AVTI is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for AVTI.
AVTI vs NGMDF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, NGMDF has a market cap of 11.51M. Regarding current trading prices, AVTI is priced at $0.00, while NGMDF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas NGMDF's P/E ratio is -5.50. In terms of profitability, AVTI's ROE is +0.25%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, AVTI is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs ATBPF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, AVTI is priced at $0.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, AVTI's ROE is +0.25%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, AVTI is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs LXXGF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, AVTI is priced at $0.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, AVTI's ROE is +0.25%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, AVTI is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs IRME Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, IRME has a market cap of 8.64M. Regarding current trading prices, AVTI is priced at $0.00, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas IRME's P/E ratio is -4.00. In terms of profitability, AVTI's ROE is +0.25%, compared to IRME's ROE of +11.77%. Regarding short-term risk, AVTI is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs TBRIF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, TBRIF has a market cap of 8.13M. Regarding current trading prices, AVTI is priced at $0.00, while TBRIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas TBRIF's P/E ratio is -1.79. In terms of profitability, AVTI's ROE is +0.25%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, AVTI is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs GTHP Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, GTHP has a market cap of 6.79M. Regarding current trading prices, AVTI is priced at $0.00, while GTHP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas GTHP's P/E ratio is -1.72. In terms of profitability, AVTI's ROE is +0.25%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, AVTI is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs MKEAF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, MKEAF has a market cap of 6.72M. Regarding current trading prices, AVTI is priced at $0.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, AVTI's ROE is +0.25%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, AVTI is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs DTXMF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, AVTI is priced at $0.00, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, AVTI's ROE is +0.25%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, AVTI is more volatile compared to DTXMF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs QLIS Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, AVTI is priced at $0.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas QLIS's P/E ratio is 2.22. In terms of profitability, AVTI's ROE is +0.25%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, AVTI is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs RHNMF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, AVTI is priced at $0.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, AVTI's ROE is +0.25%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, AVTI is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs ADMT Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, ADMT has a market cap of 4.73M. Regarding current trading prices, AVTI is priced at $0.00, while ADMT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas ADMT's P/E ratio is -7.00. In terms of profitability, AVTI's ROE is +0.25%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, AVTI is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs MICR Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, AVTI is priced at $0.00, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas MICR's P/E ratio is -3.47. In terms of profitability, AVTI's ROE is +0.25%, compared to MICR's ROE of -0.25%. Regarding short-term risk, AVTI is more volatile compared to MICR. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs FZMD Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, AVTI is priced at $0.00, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas FZMD's P/E ratio is 1.20. In terms of profitability, AVTI's ROE is +0.25%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, AVTI is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs NUMD Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, AVTI is priced at $0.00, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas NUMD's P/E ratio is 5.00. In terms of profitability, AVTI's ROE is +0.25%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, AVTI is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs LBLTF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, AVTI is priced at $0.00, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, AVTI's ROE is +0.25%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, AVTI is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for AVTI.
AVTI vs VYCO Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, VYCO has a market cap of 4.00M. Regarding current trading prices, AVTI is priced at $0.00, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas VYCO's P/E ratio is -12.00. In terms of profitability, AVTI's ROE is +0.25%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, AVTI is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs ALRTF Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, ALRTF has a market cap of 3.81M. Regarding current trading prices, AVTI is priced at $0.00, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas ALRTF's P/E ratio is -0.20. In terms of profitability, AVTI's ROE is +0.25%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, AVTI is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs USAQ Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, USAQ has a market cap of 3.67M. Regarding current trading prices, AVTI is priced at $0.00, while USAQ trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas USAQ's P/E ratio is -10.83. In terms of profitability, AVTI's ROE is +0.25%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, AVTI is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs VANIW Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, AVTI is priced at $0.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas VANIW's P/E ratio is N/A. In terms of profitability, AVTI's ROE is +0.25%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, AVTI is more volatile compared to VANIW. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs BIEL Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, BIEL has a market cap of 2.71M. Regarding current trading prices, AVTI is priced at $0.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas BIEL's P/E ratio is N/A. In terms of profitability, AVTI's ROE is +0.25%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, AVTI is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.
AVTI vs ESMC Comparison
AVTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTI stands at 1382.00. In comparison, ESMC has a market cap of 2.45M. Regarding current trading prices, AVTI is priced at $0.00, while ESMC trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTI currently has a P/E ratio of N/A, whereas ESMC's P/E ratio is 33.00. In terms of profitability, AVTI's ROE is +0.25%, compared to ESMC's ROE of +0.47%. Regarding short-term risk, AVTI is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for AVTI.